No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Boronic Acids / administration & dosage
-
Boronic Acids / adverse effects
-
Bortezomib
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Dexamethasone / administration & dosage
-
Dexamethasone / adverse effects
-
Dose-Response Relationship, Drug
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / pathology
-
Neoplasm Staging
-
Pyrazines / administration & dosage
-
Pyrazines / adverse effects
Substances
-
Boronic Acids
-
Pyrazines
-
Bortezomib
-
Dexamethasone
-
Cyclophosphamide